Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neximmune Inc (NEXI)

Neximmune Inc (NEXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neximmune Inc 9119 GAITHER ROAD GAITHERSBURG MD 20877 USA

www.neximmune.com P: 301-825-9810

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

NexImmune Inc. is a clinical-stage biotechnology company. It engages in developing a novel approach to immunotherapy designed to employ the body's own T cells to generate a specific, potent and durable immune response that mimics natural biology. NexImmune Inc. is based in GAITHERSBURG, Md.

Key Statistics

Overview:

Market Capitalization, $K 0
Enterprise Value, $K -3,220
Shares Outstanding, K 1,395
Float, K 1,187
% Float 85.10%
Short Interest, K 0
Short Float 0.01%
Days to Cover 4.15
Short Volume Ratio 0.41
% of Insider Shareholders 14.90%
% of Institutional Shareholders 9.85%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -32,340 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,330 K
EBIT, $ -20,950 K
EBITDA, $ -19,930 K

Growth:

1-Year Return 200.00%
3-Year Return -100.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 10/01/25
Earnings Per Share ttm -18.29
EPS Growth vs. Prev Year -58.27%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 10/19/23

NEXI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.00
Book Value/Share 0.51
Interest Coverage -1.36
60-Month Beta -2,212.40
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.